| Literature DB >> 26870827 |
Christoph Flückiger1, Lena Forrer2, Barbara Schnider2, Isabelle Bättig2, Guy Bodenmann2, Richard E Zinbarg3.
Abstract
BACKGROUND: Despite long-standing calls to disseminate evidence-based treatments for generalized anxiety (GAD), modest progress has been made in the study of how such treatments should be implemented. The primary objective of this study was to test three competing strategies on how to implement a cognitive behavioral treatment (CBT) for out-patients with GAD (i.e., comparison of one compensation vs. two capitalization models).Entities:
Keywords: Cognitive behavioral therapy; Evidence-based treatment; Implementation strategies; Randomized controlled trial
Mesh:
Year: 2015 PMID: 26870827 PMCID: PMC4739431 DOI: 10.1016/j.ebiom.2015.11.049
Source DB: PubMed Journal: EBioMedicine ISSN: 2352-3964 Impact factor: 8.143
Fig. 1Trial profile.
Baseline characteristics of patients and therapists.
| All enrolled subjects | Adherence priming | Resource priming | Supportive resource priming | |
|---|---|---|---|---|
| n | 57 | 19 | 19 | 19 |
| Age (SD) | 43.9 (12.1) | 42.9 (10.5) | 42.5 (13.1) | 46.3 (12.9) |
| Female/male (%) | 43/14 (25) | 12/7 (37) | 18/1 (5) | 13/6 (32) |
| Comorbidities | ||||
| At least one further diagnosis (%) | 30 (53) | 7 (37) | 12 (63) | 11 (58) |
| Anxiety disorder (%) | 20 (35) | 6 (32) | 7 (37) | 7 (37) |
| Depression (%) | 10 (18) | 1 (5) | 6 (32) | 3 (16) |
| Further treatments | ||||
| On psychotropic medication (%) | 15 (26) | 4 (21) | 7 (37) | 4 (21) |
| Past psychotherapy (%) | 24 (42) | 7 (37) | 6 (32) | 11 (58) |
| Socio cultural aspects | ||||
| Graduate occupation (%) | 19 (33) | 8 (42) | 5 (26) | 6 (32) |
| Swiss-German as first language (%) | 34 (60) | 11 (58) | 13 (68) | 10 (53) |
| On persistent close partnership (%) | 34 (60) | 11 (58) | 12 (63) | 11 (58) |
| n | 13 | 4 | 4 | 5 |
| Age (SD) | 30.2 (3.7) | 31.8 (3.9) | 29.0 (2.2) | 29.8 (5.1) |
| female/male | 13/0 | 4/0 | 4/0 | 5/0 |
| PhD degree (%) | 8 (62) | 3 (75) | 3 (75) | 2 (40) |
| Prior experience in an RCT (%) | 9 (69) | 3 (75) | 3 (75) | 3 (60) |
| Recent appointment in an in-patient clinic (%) | 5 (38) | 2 (50) | 2 (50) | 1 (20) |
| Sessions of supervision per therapy (SD) | 6.4 (4.5) | 6.5 (4.7) | 6.3 (4.3) | 6.5 (4.7) |
Descriptives of the outcome measures.
| Adherence priming | Resource priming | Supportive resource priming | Pre–post ESΔ1 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Measures | 1.–2. | 1.–3. | 2.–3. | ||||||
| BAI | |||||||||
| Intake | 19 | 23.4 (11.6) | 19 | 24.4 (12.3) | 19 | 22.7 (9.4) | |||
| Intermed | 17 | 17.1 (10.5) | 19 | 13.8 (9.1) | 17 | 11.3 (5.6) | |||
| Post | 14 | 14.8 (9.6) | 18 | 11.8 (9.1) | 17 | 9.9 (5.8) | − 0.43 | − 0.53 | − 0.03 |
| Follow-up | 15 | 13.0 (10.4) | 16 | 9.4 (8.4) | 14 | 13.7 (10.1) | |||
| PSWQ | |||||||||
| Intake | 19 | 63.2 (7.2) | 19 | 65.4 (7.8) | 19 | 63.7 (7.0) | |||
| Intermed | 17 | 59.8 (5.8) | 19 | 58.3 (8.8) | 17 | 55.8 (8.7) | |||
| Post | 14 | 55.0 (8.2) | 18 | 53.0 (11.4) | 17 | 51.2 (7.8) | − 0.42 | − 0.54 | − 0.01 |
| Follow-up | 15 | 52.6 (8.1) | 16 | 50.9 (12.5) | 14 | 50.4 (7.0) | |||
| BDI-II | |||||||||
| Intake | 19 | 16.9 (8.0) | 19 | 22.7 (10.1) | 19 | 21.4 (10.3) | |||
| Intermed | 17 | 14.4 (10.5) | 19 | 13.7 (8.2) | 17 | 15.6 (8.3) | |||
| Post | 14 | 10.6 (8.8) | 18 | 11.7 (10.5) | 17 | 10.2 (5.5) | − 0.49 | − 0.67 | − 0.02 |
| Follow-up SCL-9 | 15 | 8.7 (5.4) | 16 | 7.5 (7.5) | 14 | 10.8 (6.8) | |||
| Intake | 19 | 14.3 (7.5) | 19 | 16.4 (6.7) | 19 | 17.9 (6.7) | |||
| Intermed | 17 | 13.5 (6.5) | 19 | 11.2 (5.5) | 17 | 11.3 (5.1) | |||
| Post | 14 | 10.1 (6.7) | 18 | 8.8 (6.6) | 17 | 8.9 (5.1) | − 0.51 | − 0.81 | − 0.24 |
| Follow-up | 15 | 7.0 (4.9) | 16 | 8.0 (7.3) | 14 | 8.5 (4.9) | |||
| RES2 | |||||||||
| Intake | 19 | 116.5 (22.0) | 19 | 107.7 (31.8) | 19 | 112.0 (33.0) | |||
| Intermed | 17 | 123.3 (24.6) | 19 | 129.9 (32.9) | 17 | 126.3 (29.6) | |||
| Post | 14 | 140.0 (20.6) | 18 | 144.5 (39.7) | 17 | 144.5 (29.5) | − 0.42 | − 0.35 | 0.12 |
| Follow-up | 15 | 125.7 (31.6) | 16 | 144.7 (34.2) | 14 | 130.4 (27.5) | |||
| Outcome composite3 | |||||||||
| Intake | 19 | 55.2 (8.2) | 19 | 58.3 (10.3) | 19 | 57.7 (9.1) | |||
| Intermed | 17 | 51.9 (8.3) | 19 | 49.6 (8.8) | 17 | 48.9 (7.9) | |||
| Post | 14 | 47.8 (8.9) | 18 | 45.5 (11.4) | 17 | 45.1 (6.0) | − 0.53 | − 0.69 | − 0.02 |
| Follow-up | 15 | 45.3 (7.2) | 16 | 43.9 (10.7) | 14 | 45.8 (8.8) | |||
Legend. BAI = Beck Anxiety Inventory, PSWQ = Penn State Worry Questionnaire, BDI = Beck Depression Inventory II, SCL = Symptom Check List 9, RES = Resource Self-report Questionnaire. Intake = intake assessment, Intermed = intermediate assessment at week 6, post = post-assessment at week 14, Follow-up = 6-month follow-up.
1. = adherence priming, 2. = resource priming, 3. = supportive resource priming.
1 = Relative effect sizes (ESΔ) from intake to post-assessment; adherence priming is reference group; ES of RES is reversed.
2 = higher scores represent more resources.
3 = Standardized composite of symptom reduction of all 5 self-report questionnaires.
Growth model from intake to 6-month follow-up assessment.
| Outcome composite | ||
|---|---|---|
| Coeff (SE) | t-Ratio | |
| For intake | ||
| Base (β00) | 57.6 (2.0) | |
| Adherence priming (β01) | − 2.3 (2.7) | 0.9 |
| Resource priming (β02) | 0.4 (3.0) | 0.1 |
| For linear growth | ||
| Base (β10) | − 33.4 (6.9) | 4.9 |
| Adherence priming (β11) | 19.9 (8.9) | 2.2 |
| Resource priming (β12) | 5.1 (10.2) | 0.5 |
| For quadratic growth | ||
| Base (β20) | 21.4 (6.7) | 3.2 |
| Adherence priming (β21) | − 17.0 (8.6) | 2.2 |
| Resource priming (β22) | − 6.4 (9.0) | 0.7 |
| Level 2 intercept (r0j) | 45.5 | |
| Level 2 linear growth (r1j) | 18.9 | |
| Level 1 ( | 28.5 | |
dfs for t-ratio = 54; 194.
Outcome composite of symptom reduction based on BAI, PSWQ, BDI-II, SCL-9, and RES.
p < 0.05.
p < 0.01.
p < 0.001.
Fig. 2Growth models of symptom reduction from intake to follow-up assessment.
Legend: M = 50, SD = 10; standardized outcome composite of 5 self-report questionnaires BAI, PSWQ, BDI-II, SCL-9, and RES.
In-session competence ratings.
| CTS-G | Adherence priming | Resource priming | Supportive resource priming | Posthoc1 |
|---|---|---|---|---|
| Resource activation | 4.0 (0.09) | 4.6 (0.09) | 4.4 (0.08) | 1. < 2. = 3. |
| Session-structuring comp. | 3.9 (0.09) | 4.3 (0.09) | 3.9 (0.08) | 1. = 3. < 2. |
| General therapeutic comp. | 4.0 (0.07) | 4.3 (0.07) | 4.1 (0.06) | 1. = 3. < 2. |
1. = adherence priming, 2. = resource priming, 3. = supportive resource priming, CTS-G = Cognitive Therapy Scale — German version.
1 = Tukey.
n = 100 sessions.